|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calvert PM and Frucht H: The genetics of
colorectal cancer. Ann Intern Med. 137:603–612. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei EK, Wolin KY and Colditz GA: Time
course of risk factors in cancer etiology and progression. J Clin
Oncol. 28:4052–4057. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dai L, Cui X, Zhang X, Cheng L, Liu Y,
Yang Y, Fan P, Wang Q, Lin Y, Zhang J, et al: SARI inhibits
angiogenesis and tumour growth of human colon cancer through
directly targeting ceruloplasmin. Nat Commun. 7:119962016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chawla JP, Iyer N, Soodan KS, Sharma A,
Khurana SK and Priyadarshni P: Role of miRNA in cancer diagnosis,
prognosis, therapy and regulation of its expression by Epstein-Barr
virus and human papillomaviruses: With special reference to oral
cancer. Oral Oncol. 51:731–737. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gambari R, Brognara E, Spandidos DA and
Fabbri E: Targeting oncomiRNAs and mimicking tumor suppressor
miRNAs: Nuew trends in the development of miRNA therapeutic
strategies in oncology (Review). Int J Oncol. 49:5–32. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, Xu Z, Li B, Zhang Z, Luo H, Wang Y,
Lu Z and Wu X: Epigenetic silencing of miRNA-9 is correlated with
promoter-proximal CpG island hypermethylation in gastric cancer in
vitro and in vivo. Int J Oncol. 45:2576–2586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lv J, Xia K, Xu P, Sun E, Ma J, Gao S,
Zhou Q, Zhang M, Wang F, Chen F, et al: miRNA expression patterns
in chemoresistant breast cancer tissues. Biomed Pharmacother.
68:935–942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Molina-Pinelo S, Carnero A, Rivera F,
Estevez-Garcia P, Bozada JM, Limon ML, Benavent M, Gomez J, Pastor
MD, Chaves M, et al: MiR-107 and miR-99a-3p predict chemotherapy
response in patients with advanced colorectal cancer. BMC Cancer.
14:6562014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nadal E, Zhong J, Lin J, Reddy RM, Ramnath
N, Orringer MB, Chang AC, Beer DG and Chen G: A MicroRNA cluster at
14q32 drives aggressive lung adenocarcinoma. Clin Cancer Res.
20:3107–3117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yungang W, Xiaoyu L, Pang T, Wenming L and
Pan X: miR-370 targeted FoxM1 functions as a tumor suppressor in
laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother.
68:149–154. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen XP, Chen YG, Lan JY and Shen ZJ:
MicroRNA-370 suppresses proliferation and promotes endometrioid
ovarian cancer chemosensitivity to cDDP by negatively regulating
ENG. Cancer Lett. 353:201–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Z, Sun H, Zeng W, He J and Mao X:
Upregulation of MircoRNA-370 induces proliferation in human
prostate cancer cells by downregulating the transcription factor
FOXO1. PLoS One. 7:e458252012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo P, He T, Jiang R and Li G:
MicroRNA-423-5p targets O-GlcNAc transferase to induce apoptosis in
cardiomyocytes. Mol Med Rep. 12:1163–1168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeng Y, Fu M, Wu GW, Zhang AZ, Chen JP,
Lin HY, Fu YA, Jia J, Cai ZD, Wu XJ and Lan P: Upregulation of
microRNA-370 promotes cell apoptosis and inhibits proliferation by
targeting PTEN in human gastric cancer. Int J Oncol. 49:1589–1599.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lo SS, Hung PS, Chen JH, Tu HF, Fang WL,
Chen CY, Chen WT, Gong NR and Wu CW: Overexpression of miR-370 and
downregulation of its novel target TGFbeta-RII contribute to the
progression of gastric carcinoma. Oncogene. 31:226–237. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen T, Gao F, Feng S, Yang T and Chen M:
MicroRNA-370 inhibits the progression of non-small cell lung cancer
by downregulating oncogene TRAF4. Oncol Rep. 34:461–468. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meng F, Wehbe-Janek H, Henson R, Smith H
and Patel T: Epigenetic regulation of microRNA-370 by interleukin-6
in malignant human cholangiocytes. Oncogene. 27:378–386. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hirose M, Yamato K, Endo S, Saito R, Ueno
T, Hirai S, Suzuki H, Abei M, Natori Y and Hyodo I: MDM4 expression
as an indicator of TP53 reactivation by combined targeting of MDM2
and MDM4 in cancer cells without TP53 mutation. Oncoscience.
1:830–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tan BX, Khoo KH, Lim TM and Lane DP: High
Mdm4 levels suppress p53 activity and enhance its half-life in
acute myeloid leukaemia. Oncotarget. 5:933–943. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang MJ, Luo YJ, Shi ZY, Xu XL, Yao GL,
Liu RP and Zhao H: The associations between MDM4 gene polymorphisms
and cancer risk. Oncotarget. 7:55611–55623. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gilkes DM, Pan Y, Coppola D, Yeatman T,
Reuther GW and Chen J: Regulation of MDMX expression by mitogenic
signaling. Mol Cell Biol. 28:1999–2010. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ling X, Xu C, Fan C, Zhong K, Li F and
Wang X: FL118 induces p53-dependent senescence in colorectal cancer
cells by promoting degradation of MdmX. Cancer Res. 74:7487–7497.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mandke P, Wyatt N, Fraser J, Bates B,
Berberich SJ and Markey MP: MicroRNA-34a modulates MDM4 expression
via a target site in the open reading frame. PLoS One.
7:e420342012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Markey M and Berberich SJ: Full-length
hdmX transcripts decrease following genotoxic stress. Oncogene.
27:6657–6666. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li C, Ge Q, Liu J, Zhang Q, Wang C, Cui K
and Chen Z: Effects of miR-1236-3p and miR-370-5p on activation of
p21 in various tumors and its inhibition on the growth of lung
cancer cells. Tumour Biol. 39:10104283177108242017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan XP, Wang HX, Tong DM, Li Y, Huang LH
and Wang C: miRNA-370 acts as a tumor suppressor via the
downregulation of PIM1 in hepatocellular carcinoma. Eur Rev Med
Pharmacol Sci. 21:1254–1263. 2017.PubMed/NCBI
|
